Buyer Name: NHS ENGLAND
Buyer Address: NHS England, 7&8 Wellington Place, Leeds, UKE42, LS1 4AP, United Kingdom
Contact Email: england.commercialqueries@nhs.net
Buyer Name: NHS ENGLAND
Buyer Address: NHS England, 7&8 Wellington Place, Leeds, UKE42, LS1 4AP, United Kingdom
Contact Email: england.commercialqueries@nhs.net
The Diabetic Eye Screening Test and Training (DES TAT) system is crucial for the NHS Diabetic Eye Screening Programme (DESP), ensuring staff are trained to detect diabetic retinopathy accurately. This vital quality assurance minimizes diagnostic variability, helping to prevent blindness in diabetic patients. The Discovery project (BC-21699) will evaluate DES TAT to confirm its alignment with modern digital standards, assessing user needs, functionality, and infrastructure. The project will explore enhancements, cost-efficiencies, and potential integration with PERFORMS TAT and PERFECT TAT into a unified modular system. Key goals include validating user requirements, reviewing the current infrastructure for compliance and improvement, enhancing cost-efficiency, and defining a Minimum Viable Product (MVP). The aim is to modernize DES TAT while retaining essential features and exploring decommissioning outdated components.
No linked documents found for this notice.
Lot 1 Status: complete
Document Description: Not published
Award Title: STA -Diabetic Eye Screening (DES TAT) 25/26
{
"awards": [
{
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2026-10-31T23:59:59Z",
"startDate": "2025-11-06T00:00:00Z"
},
"documents": [
{
"datePublished": "2025-11-05T11:50:56Z",
"description": "Transparency notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "071208-2025",
"noticeType": "UK5",
"url": "https://www.find-tender.service.gov.uk/Notice/071208-2025"
}
],
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Health services",
"id": "85100000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "services",
"milestones": [
{
"dueDate": "2025-11-05T23:59:59Z",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"1"
],
"status": "pending",
"suppliers": [
{
"id": "GB-NHS-RTE",
"name": "GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST"
}
],
"title": "STA -Diabetic Eye Screening (DES TAT) 25/26",
"value": {
"amount": 197122.67,
"amountGross": 236547.2,
"currency": "GBP"
}
}
],
"buyer": {
"id": "GB-NHS-X24",
"name": "NHS ENGLAND"
},
"date": "2025-11-05T11:50:56Z",
"id": "071208-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05dacf",
"parties": [
{
"additionalIdentifiers": [
{
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Leeds",
"postalCode": "LS1 4AP",
"region": "UKE42",
"streetAddress": "NHS England, 7\u00268 Wellington Place"
},
"contactPoint": {
"email": "england.commercialqueries@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
]
},
"id": "GB-NHS-X24",
"identifier": {
"id": "X24",
"scheme": "GB-NHS"
},
"name": "NHS ENGLAND",
"roles": [
"buyer"
]
},
{
"additionalIdentifiers": [
{
"id": "PYHT-5943-VXGV",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Gloucester",
"postalCode": "GL53 7AN",
"region": "UKK13",
"streetAddress": "Alexandra House, Cheltenham General Hospital, Sandford Road"
},
"contactPoint": {
"email": "edward.taylor1@nhs.net"
},
"id": "GB-NHS-RTE",
"identifier": {
"id": "RTE",
"scheme": "GB-NHS"
},
"name": "GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "The Diabetic Eye Screening Test and Training (DES TAT) system is crucial for the NHS Diabetic Eye Screening Programme (DESP), ensuring staff are trained to detect diabetic retinopathy accurately. This vital quality assurance minimizes diagnostic variability, helping to prevent blindness in diabetic patients.\nThe Discovery project (BC-21699) will evaluate DES TAT to confirm its alignment with modern digital standards, assessing user needs, functionality, and infrastructure. The project will explore enhancements, cost-efficiencies, and potential integration with PERFORMS TAT and PERFECT TAT into a unified modular system.\nKey goals include validating user requirements, reviewing the current infrastructure for compliance and improvement, enhancing cost-efficiency, and defining a Minimum Viable Product (MVP). The aim is to modernize DES TAT while retaining essential features and exploring decommissioning outdated components.",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "C382056",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "Technical reasons",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersTechnicalReasons"
}
],
"status": "complete",
"title": "Diabetic Eye Screening (DES TAT) 25/26"
}
}